HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
25 avr. 2024 07h01 HE
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback ...
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
09 déc. 2019 08h45 HE
|
Abeona Therapeutics Inc.
FDA removes clinical hold; Company may proceed with VIITAL™ study Company expects to initiate study in the first quarter of 2020 Primary endpoint confirmed as proportion of wounds with greater than...
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of SRC Energy, Pivotal Software, MAM Software Group, and Fibrocell Science on behalf of Stockholders and Encourages Investors to Contact the Firm
15 oct. 2019 10h56 HE
|
Bragar Eagel & Squire
NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of SRC Energy Inc. (NYSE:...
Atos permet une adoption plus rapide du cloud avec les nouveaux accélérateurs Syntbots pour la Plateforme Pivotal
09 oct. 2019 08h00 HE
|
Atos International
Atos permet une adoption plus rapide du cloud avec les nouveaux accélérateurs SyntBots pour la Plateforme Pivotal Paris, France - le 9 octobre 2019 – Atos, leader international de la...
Atos Delivers Faster Cloud Adoption with New Syntbots Accelerators for Pivotal Platform
09 oct. 2019 08h00 HE
|
Atos International
Atos Delivers Faster Cloud Adoption with New SyntBots Accelerators for Pivotal Platform Paris, France - October 9, 2019 – Atos, a global leader in digital transformation, today announced...
Atos remporte le prix du Partenaire intégrateur de systèmes innovant de l’année décerné par Pivotal
08 oct. 2019 08h00 HE
|
Atos International
Paris, le 8 octobre 2019 – Atos, leader international de la transformation digitale, annonce aujourd’hui avoir été nommé le partenaire intégrateur de systèmes innovant de l’année pour la zone EMEA...
Atos wins Breakthrough System Integrator Partner of the Year Award from Pivotal
08 oct. 2019 08h00 HE
|
Atos International
Paris, France, October 8 2019 – Atos, global leader in digital transformation, today announces that it has been named a Breakthrough System Integrator Partner of the Year for EMEA by Pivotal Software,...
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
03 sept. 2019 07h00 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 03, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pivotal Software, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
18 juin 2019 12h20 HE
|
Schall Law
LOS ANGELES, June 18, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pivotal...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pivotal Software, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
10 juin 2019 14h23 HE
|
Schall Law
LOS ANGELES, June 10, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pivotal...